Literature DB >> 3263645

Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.

E Leitersdorf1, H H Hobbs, A M Fourie, M Jacobs, D R van der Westhuyzen, G A Coetzee.   

Abstract

The ligand-binding domain of the low density lipoprotein (LDL) receptor is composed of seven cysteine-rich repeats, each approximately 40 amino acids long. Previous studies by van Driel et al. [van Driel, I. R., Goldstein, J. L., Sudhof, T. C. & Brown, M. S. (1987) J. Biol. Chem. 262, 17443-17449] showed that if the first repeat of the ligand-binding domain (encoded by exon 2) is deleted, the receptor fails to bind an anti-LDL receptor monoclonal antibody (IgG-C7) but continues to bind LDL with high affinity. Cultured fibroblasts from a Black South African Xhosa patient (TT) with the clinical syndrome of homozygous familial hypercholesterolemia demonstrated high-affinity cell-surface binding of 125I-labeled LDL but not 125I-labeled IgG-C7. Previous haplotype analysis, using 10 restriction fragment length polymorphic sites, suggested that the patient inherited two identical LDL receptor alleles. The polymerase chain reaction technique was used to selectively amplify exon 2 of the LDL receptor gene from this patient. Sequence analysis of the amplified fragment disclosed a deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat. The mutation creates a new PstI restriction site that can be used to detect the deletion. The existence of this mutant allele confirms that the epitope of IgG-C7 is located in the first cysteine-rich repeat and that this repeat is not necessary for LDL binding. The mutant gene produced a normally sized 120-kilodalton LDL receptor precursor protein that matured to the 160-kilodalton form at less than one-fourth the normal rate. Thus, deletion of two amino acids within the first cysteine-rich repeat retards receptor transport from the endoplasmic reticulum to the cell surface, in contrast to deletion of the entire first repeat, which has no effect on receptor maturation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263645      PMCID: PMC282319          DOI: 10.1073/pnas.85.21.7912

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).

Authors:  S Yoshitake; B G Schach; D C Foster; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

2.  Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor.

Authors:  D W Russell; W J Schneider; T Yamamoto; K L Luskey; M S Brown; J L Goldstein
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

3.  Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia.

Authors:  H H Hobbs; M S Brown; J L Goldstein; D W Russell
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

4.  The LDL receptor gene: a mosaic of exons shared with different proteins.

Authors:  T C Südhof; J L Goldstein; M S Brown; D W Russell
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

5.  Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit.

Authors:  T Yamamoto; R W Bishop; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

6.  Low density lipoprotein receptor mutations in South African homozygous familial hypercholesterolemic patients.

Authors:  D R van der Westhuyzen; G A Coetzee; I P Demasius; E H Harley; W Gevers; S G Baker; H C Seftel
Journal:  Arteriosclerosis       Date:  1984 May-Jun

7.  Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin.

Authors:  J C Edman; L Ellis; R W Blacher; R A Roth; W J Rutter
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

8.  Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport.

Authors:  M J Gething; K McCammon; J Sambrook
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

9.  Biosynthesis and intracellular sorting of growth hormone-viral envelope glycoprotein hybrids.

Authors:  L J Rizzolo; J Finidori; A Gonzalez; M Arpin; I E Ivanov; M Adesnik; D D Sabatini
Journal:  J Cell Biol       Date:  1985-10       Impact factor: 10.539

10.  Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface.

Authors:  T E Kreis; H F Lodish
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

View more
  16 in total

1.  Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

Authors:  M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

Review 2.  Application of the polymerase chain reaction to the diagnosis of human genetic disease.

Authors:  J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

3.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

4.  Low-density-lipoprotein receptors in human fibroblasts are not degraded in lysosomes.

Authors:  L A Casciola; K I Grant; W Gevers; G A Coetzee; D R van der Westhuyzen
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

5.  Efficient TALEN-mediated gene knockout in livestock.

Authors:  Daniel F Carlson; Wenfang Tan; Simon G Lillico; Dana Stverakova; Chris Proudfoot; Michelle Christian; Daniel F Voytas; Charles R Long; C Bruce A Whitelaw; Scott C Fahrenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

6.  Multiple mutations underlying familial hypercholesterolemia in the South African population.

Authors:  H E Henderson; M J Kotze; G M Berger
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

7.  Common low-density lipoprotein receptor mutations in the French Canadian population.

Authors:  E Leitersdorf; E J Tobin; J Davignon; H H Hobbs
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

8.  An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations.

Authors:  Maria Romano; Maria Donata Di Taranto; Peppino Mirabelli; Maria Nicoletta D'Agostino; Arcangelo Iannuzzi; Gennaro Marotta; Marco Gentile; Maddalena Raia; Rosa Di Noto; Luigi Del Vecchio; Paolo Rubba; Giuliana Fortunato
Journal:  J Lipid Res       Date:  2011-08-24       Impact factor: 5.922

9.  The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.

Authors:  U M Koivisto; H Turtola; K Aalto-Setälä; B Top; R R Frants; P T Kovanen; A C Syvänen; K Kontula
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

10.  Two novel frameshift mutations associated with the presence of direct repeats of the LDL receptor gene in familial hypercholesterolemia.

Authors:  K Yamakawa-Kobayashi; T Kobayashi; K Saku; K Arakawa; H Hamaguchi
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.